ibrutinib,rituximab
abbvie,janssen
[' ibru', 'lymsm']
standing room only at the #ash22 plenary session presenting the highest-caliber scientific abstracts at this years meeting. martin dreyling presents on the triangle study of ibrutinib with standard therapy +/- asct for frontline treatment of #mcl #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm